Building Momentum - Acceleration Biotech Innovation in Europe

Success, failure, and the road to 3.9 billion: Edwin Moses on building biotech giants

Listen, learn, understand: the voices of patients driving innovation

Eli Lilly chooses Leiden Bio Science Park for major expansion, boosting the Netherlands’ life-sciences ecosystem

Argenx: ‘Innovation is at the core of our business’

Flerie takes a different approach to investing in biotechnology - Ted Fjällman, CEO of investment company Flerie, talks about the biotechnology investment firm's strategy